eISSN : 2146-9369
Creative Commons Lisansı
Journal of Clinical and Experimental Investigations is licenced under the terms of Creative Commons Attribution-Non Commercial4.0 International (CC BY-NC 4.0) License.
Abstract - Composite Adverse Event Outcome in Pediatric Cancer Patients with Prolonged Febrile Neutropenia
Muhammd Matloob Alam

Muhammad Matloob Alam

Muhammad Matloob Alam,

Pediatric Hematology & OncologyDepartment of Paediatrics & Child Health Aga Khan University Hospital Stadium Road, PO Box 3500, Karachi -74800, Pakistan Email: dr.matloobalam@hotmail.com

Composite Adverse Event Outcome in Pediatric Cancer Patients with Prolonged Febrile Neutropenia

ABSTRACT

Objective: Pediatric cancer patients with prolonged febrile neutropenia have increased risk for severe, recurrent or new bacterial and fungal infection. The aim of this study was to identify the risk factors associated with adverse outcomes in this group.

Methods: We retrospective analyzed the clinical data of 135 hospitalizations of pediatric cancer patients with pro­longed febrile neutropenia from a tertiary health care center of Pakistan.

Results: The mean age of the study population was 7.3±4.1 years. There were 98 (72.6%) males and 37 (27.4%) females. Acute leukemia with 88 patients (65.2%) was the most common diagnosis followed by lymphomas 19 patients (14.1%) and solid tumors. Cause of febrile neutropenia was identified in only 58 (43.0%) patients, out of them blood stream infections were found in 22 cases (16.3%), pneumonia in 15 (11.1%), fungal infection in 13 (9.6%), infectious diarrheas in 5 (3.7%) and urinary tract infection (UTI) in 3 (2.2%) of cases. The composite adverse event outcome was observed in 28 (20.7%) of patients, with in-hospital mortality occurring in 7 (5.2%), Pediatric intensive care unit (PICU) admission occurring in 12 (8.9%) and inotropic support was required in 9 (6.7%). On logistic regression analysis AML (Adjusted odds ratio (AOR), 7.6; P<0.001), neutropenia <50/mm3 (AOR, 10.8; p<0.001), platelets count <50,000/mm3 (AOR, 5.2; p<0.001), BSI (AOR, 2.3; p 0.05) and fungal infection (AOR, 4.3; p<0.001) were found as independent risk factors for composite adverse event outcome in pediatric cancer patients with prolonged febrile neutropenia.

Conclusions: AML, severe myelosuppression, blood stream infections and fungal infection were identifiable risk factors associated with development of adverse event outcome in pediatric cancer patients with prolonged febrile neutropenia. J Microbiol Infect Dis 2016;6(2): 69-73

Muhammad Matloob Alam, Pediatric Hematology & OncologyDepartment of Paediatrics & Child Health Aga Khan University Hospital Stadium Road, PO Box 3500, Karachi -74800, Pakistan Email: dr.matloobalam@hotmail.com Composite Adverse Event Outcome in Pediatric Cancer Patients with Prolonged Febrile Neutropenia,  Muhammad Matloob Alam J Microbiol Infect Dis 2016;6(2): 69-73 doi: 10.5799/ahinjs.02.2016.02.0219 Volume 06, Number 02 (2016)

Volume 06, Number 02 (2016)